Conference Proceedings

Clinical activity of adenosine 2A receptor (A2AR) inhibitor CPI-444 is associated with tumor expression of adenosine pathway genes and tumor immune modulation

Andrew Hotson, John Powderly, Leisha Emens, Patrick Forde, Matthew Hellman, Lawrence Fong, Ben Markman, Brett Hughes, Jonathan Goldman, Mario Sznol, Daruka Mahadevan, Shivaani Kummar, Joshua Brody, Philip Bonomi, Jason Luke, Matthew Riese, Taofeek Owonikoko, Sherene Loi, Amy Wiese, Robert Doebele Show all

JOURNAL FOR IMMUNOTHERAPY OF CANCER | BMC | Published : 2017